Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Radiation-related cancer risk associated with surveillance imaging for metastasis from choroidal melanoma.

Wen JC, Sai V, Straatsma BR, McCannel TA.

JAMA Ophthalmol. 2013 Jan;131(1):56-61. doi: 10.1001/jamaophthalmol.2013.564.

PMID:
23307209
2.

Initial PET/CT staging for choroidal melanoma: AJCC correlation and second nonocular primaries in 333 patients.

Freton A, Chin KJ, Raut R, Tena LB, Kivelä T, Finger PT.

Eur J Ophthalmol. 2012 Mar-Apr;22(2):236-43. doi: 10.5301/ejo.5000049.

PMID:
21959680
3.

Whole-body PET/CT scanning: estimation of radiation dose and cancer risk.

Huang B, Law MW, Khong PL.

Radiology. 2009 Apr;251(1):166-74. doi: 10.1148/radiol.2511081300. Epub 2009 Feb 27.

PMID:
19251940
4.

Whole body PET/CT for initial staging of choroidal melanoma.

Finger PT, Kurli M, Reddy S, Tena LB, Pavlick AC.

Br J Ophthalmol. 2005 Oct;89(10):1270-4.

5.

Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.

Kurli M, Reddy S, Tena LB, Pavlick AC, Finger PT.

Am J Ophthalmol. 2005 Aug;140(2):193-9.

PMID:
15992753
6.

Utility of the PET-CT scan with (18)F-FDG in a case of choroid melanoma recurrence.

Sabate M, García JR, Valls E, Moragas M, Soler M, Riera E, Lomeña F.

Rev Esp Med Nucl Imagen Mol. 2012 May-Jun;31(3):167-8. doi: 10.1016/j.remn.2011.10.009. Epub 2011 Dec 15. English, Spanish. No abstract available.

7.

Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.

Eaton BR, Kim HS, Schreibmann E, Schuster DM, Galt JR, Barron B, Kim S, Liu Y, Landry J, Fox T.

J Vasc Interv Radiol. 2014 Feb;25(2):288-95. doi: 10.1016/j.jvir.2013.08.021. Epub 2013 Oct 23.

PMID:
24269792
8.

Major trauma & cervical clearance radiation doses & cancer induction.

Richards PJ, Summerfield R, George J, Hamid A, Oakley P.

Injury. 2008 Mar;39(3):347-56. Epub 2007 Oct 4.

PMID:
17919637
9.

Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography.

Tarin TV, Sonn G, Shinghal R.

J Urol. 2009 Feb;181(2):627-32; discussion 632-3. doi: 10.1016/j.juro.2008.10.005. Epub 2008 Dec 16.

PMID:
19091344
10.

Choroidal melanoma with hematogenous spread to the liver: F-18 FDG PET/CT findings.

Bawa M, Sidhu G, Galt JR, Schuster DM, Halkar RK.

Clin Nucl Med. 2006 Jun;31(6):347-8. No abstract available.

PMID:
16714898
11.

18FDG-PET/CT assessing the absence of cell viability and excluding metastatic disease in a case of necrotic choroidal melanoma.

Romero-Aroca P, Montero-Jaime M, Intriago B, Riu F, Peña-Gonzalez KB, Almena-Garcia M.

Eur J Ophthalmol. 2012 Mar-Apr;22(2):288-92. doi: 10.5301/ejo.5000016.

PMID:
21725939
12.

[(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) physiologic imaging of choroidal melanoma: before and after ophthalmic plaque radiation therapy.

Finger PT, Chin KJ.

Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):137-42. doi: 10.1016/j.ijrobp.2009.10.041. Epub 2010 Apr 13.

PMID:
20395070
13.

Estimated radiation exposure and cancer risk from CT and PET/CT scans in patients with lymphoma.

Guttikonda R, Herts BR, Dong F, Baker ME, Fenner KB, Pohlman B.

Eur J Radiol. 2014 Jun;83(6):1011-1015. doi: 10.1016/j.ejrad.2014.02.015. Epub 2014 Feb 24.

PMID:
24656401
14.

Radiation-related cancer risk associated with radiographic imaging.

Finger PT, Freton A, Pavlick A.

JAMA Ophthalmol. 2013 Sep;131(9):1248-9. doi: 10.1001/jamaophthalmol.2013.4025. No abstract available.

PMID:
24030341
15.

Radiation-related cancer risk associated with radiographic imaging--reply.

Wen JC, Sai V, Straatsma BR, McCannel TA.

JAMA Ophthalmol. 2013 Sep;131(9):1249. doi: 10.1001/jamaophthalmol.2013.4507. No abstract available.

PMID:
24030343
16.

The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk.

Miglioretti DL, Johnson E, Williams A, Greenlee RT, Weinmann S, Solberg LI, Feigelson HS, Roblin D, Flynn MJ, Vanneman N, Smith-Bindman R.

JAMA Pediatr. 2013 Aug 1;167(8):700-7. doi: 10.1001/jamapediatrics.2013.311.

17.

Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis.

Rampinelli C, De Marco P, Origgi D, Maisonneuve P, Casiraghi M, Veronesi G, Spaggiari L, Bellomi M.

BMJ. 2017 Feb 8;356:j347. doi: 10.1136/bmj.j347.

18.

PET/CT imaging: detection of choroidal melanoma.

Reddy S, Kurli M, Tena LB, Finger PT.

Br J Ophthalmol. 2005 Oct;89(10):1265-9.

19.

(18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.

Orcurto V, Denys A, Voelter V, Schalenbourg A, Schnyder P, Zografos L, Leyvraz S, Delaloye AB, Prior JO.

Melanoma Res. 2012 Feb;22(1):63-9. doi: 10.1097/CMR.0b013e32834d3dcb.

PMID:
22027909
20.

Patient doses from PET-CT procedures.

Avramova-Cholakova S, Ivanova S, Petrova E, Garcheva M, Vassileva J.

Radiat Prot Dosimetry. 2015 Jul;165(1-4):430-3. doi: 10.1093/rpd/ncv128. Epub 2015 Apr 5.

PMID:
25848105

Supplemental Content

Support Center